FRONTAGE LABS

Company Overview

Frontage Labs is a CRO that offers scientifically driven research and analytical services and is engaged in drug discovery and the development process to empower life science companies to accomplish drug development goals. The company deals with biotechnology companies, small, mid-sized and large biopharmaceutical companies, small CROs, life science companies, agricultural and industrial chemical companies, contract manufacturing companies and diagnostics. It also serves other commercial units, academic institutions, hospitals and government agencies.

The company mainly operates in North America (U.S. and Canada) and PRC. Its business segments are North America and PRC. It serves its clientele through its product categories including drug discovery, drug development, pharmaceutical product development and laboratory testing. Its customer base is in North America, Europe, Japan, Australia, Korea and Israel. 

Financial Highlights (FY 2024)

Company's Business Segments

• Drug Discovery : Medicinal Chemistry, Pharmacology, Efficacy & Absorption, Distribution, Metabolism, Excretion (“ADME”) Screening
• Drug Development : Drug Metabolism and Pharmacokinetics, Safety and Toxicology, Early Phase Clinical Services, Pharmacology, Medical Writing
• Pharmaceutical Product Development : Active Pharmaceutical Ingredient (“API”) Synthesis, Process and Formulation Development, Clinical Trial Material Manufacturing
• Laboratory Testing : Bioanalysis, Biomarkers, Genomics, CMC Analytical Testing, Central Laboratory Services